Zobrazeno 1 - 2
of 2
pro vyhledávání: '"B. S. Adiwijaya"'
Autor:
B. Melichar, T. Csõszi, I. Lang, Jun Suk Kim, B. Belanger, Jung Sub Kim, J. B. Gallego, Joon Oh Park, A. Cubillo, Kun-Ming Rau, Wen Wee Ma, Mark Wong, B. S. Adiwijaya, J. Fitzgerald, Jen-Shi Chen, I. Molnar
Publikováno v:
Clinical Pharmacology and Therapeutics
Nanoliposomal irinotecan (nal-IRI) is a liposomal formulation of irinotecan with a longer half-life (t1/2 ), higher plasma total irinotecan (tIRI), and lower SN-38 maximum concentration (Cmax ) compared with nonliposomal irinotecan. Population pharma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce5cb12728b7f574cd1c20fc5ef264b
http://europepmc.org/articles/PMC5697569
http://europepmc.org/articles/PMC5697569
Autor:
Antonio Cubillo, Joon Oh Park, Mark Wong, Javier Gallego, Bruce Belanger, Ik-Joo Chung, Bohuslav Melichar, Jen-Shi Chen, István Láng, Wen Wee Ma, Jung Sub Kim, B. S. Adiwijaya, E. Bayever, Tibor Csoszi, M. Smakal, M.W. Wenczl, Jun Suk Kim, K.M. Rau
Publikováno v:
European Journal of Cancer. 51:S458
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b63815b04fc766c3e7d58058e40b98c
https://doi.org/10.1016/s0959-8049(16)31281-3
https://doi.org/10.1016/s0959-8049(16)31281-3